References
[1] Glauber M, Miceli A. State of the art for approaching the mitral valve: sternotomy, minimally invasive or total endoscopic robotic? Eur J Cardiothorac Surg 2015;48:639–41. doi:10.1093/ejcts/ezv312.
[2] Modi P, Hassan A, Chitwood WR. Minimally invasive mitral valve surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2008;34:943–52. doi:10.1016/j.ejcts.2008.07.057.
[3] Cheng DCH, Martin J, Lal A, Diegeler A, Folliguet TA, Nifong LW, et al. Minimally invasive versus conventional open mitral valve surgery: a meta-analysis and systematic review. Innovations (Phila) 2011;6:84–103. doi:10.1097/IMI.0b013e3182167feb.
[4] Raanani E, Spiegelstein D, Sternik L, Preisman S, Moshkovitz Y, Smolinsky AK, et al. Quality of mitral valve repair: median sternotomy versus port-access approach. J Thorac Cardiovasc Surg 2010;140:86–90. doi:10.1016/j.jtcvs.2009.09.035.
[5] Iribarne A, Russo MJ, Easterwood R, Hong KN, Yang J, Cheema FH, et al. Minimally invasive versus sternotomy approach for mitral valve surgery: a propensity analysis. Ann Thorac Surg 2010;90:1471–7–discussion1477–8. doi:10.1016/j.athoracsur.2010.06.034.
[6] Goldstone AB, Atluri P, Szeto WY, Trubelja A, Howard JL, MacArthur JW, et al. Minimally invasive approach provides at least equivalent results for surgical correction of mitral regurgitation: a propensity-matched comparison. J Thorac Cardiovasc Surg 2013;145:748–56. doi:10.1016/j.jtcvs.2012.09.093.
[7] McClure RS, Athanasopoulos LV, McGurk S, Davidson MJ, Couper GS, Cohn LH. One thousand minimally invasive mitral valve operations: early outcomes, late outcomes, and echocardiographic follow-up. J Thorac Cardiovasc Surg 2013;145:1199–206. doi:10.1016/j.jtcvs.2012.12.070.
[8] Murzi M, Cerillo AG, Miceli A, Bevilacqua S, Kallushi E, Farneti P, et al. Antegrade and retrograde arterial perfusion strategy in minimally invasive mitral-valve surgery: a propensity score analysis on 1280 patients. Eur J Cardiothorac Surg 2013;43:e167–72. doi:10.1093/ejcts/ezt043.
[9] Yoo JS, Kim JB, Jung S-H, Choo SJ, Chung CH, Lee JW. Echocardiographic assessment of mitral durability in the late period following mitral valve repair: minithoracotomy versus conventional sternotomy. J Thorac Cardiovasc Surg 2014;147:1547–52. doi:10.1016/j.jtcvs.2013.05.042.
[10] Glauber M, Miceli A, Canarutto D, Lio A, Murzi M, Gilmanov D, et al. Early and long-term outcomes of minimally invasive mitral valve surgery through right minithoracotomy: a 10-year experience in 1604 patients. J Cardiothorac Surg 2015;10:181. doi:10.1186/s13019-015-0390-y.
[11] Atluri P, Stetson RL, Hung G, Gaffey AC, Szeto WY, Acker MA, et al. Minimally invasive mitral valve surgery is associated with equivalent cost and shorter hospital stay when compared with traditional sternotomy. J Thorac Cardiovasc Surg 2016;151:385–8. doi:10.1016/j.jtcvs.2015.08.106.
[12] Lange R, Voss B, Kehl V, Mazzitelli D, Tassani-Prell P, Günther T. Right Minithoracotomy Versus Full Sternotomy for Mitral Valve Repair: A Propensity Matched Comparison. Ann Thorac Surg 2017;103:573–9. doi:10.1016/j.athoracsur.2016.06.055.
[13] Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg 2008;85:1490–5. doi:10.1016/j.athoracsur.2007.12.082.
[14] Tatum JM, Bowdish ME, Mack WJ, Quinn AM, Cohen RG, Hackmann AE, et al. Outcomes after mitral valve repair: A single-center 16-year experience. J Thorac Cardiovasc Surg 2017. doi:10.1016/j.jtcvs.2017.01.047.
[15] Fine JP, Gray RJ. A Proportional Hazards Model for the Subdistribution of a Competing Risk. Journal of the American Statistical Association 2012. doi:10.1080/01621459.1999.10474144;page:string:Article/Chapter.
[16] Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. The Annals of Statistics 1988. doi:10.2307/2241622.
[17] Coutinho GF, Antunes MJ. Mitral valve repair for degenerative mitral valve disease: surgical approach, patient selection and long-term outcomes. Heart 2017:heartjnl–2016–311031. doi:10.1136/heartjnl-2016-311031.
[18] Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017:CIR.0000000000000503. doi:10.1161/CIR.0000000000000503.
[19] David TE, Armstrong S, McCrindle BW, Manlhiot C. Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation 2013;127:1485–92. doi:10.1161/CIRCULATIONAHA.112.000699.
[20] DiBardino DJ, ElBardissi AW, McClure RS, Razo-Vasquez OA, Kelly NE, Cohn LH. Four decades of experience with mitral valve repair: analysis of differential indications, technical evolution, and long-term outcome. J Thorac Cardiovasc Surg 2010;139:76–83–discussion83–4. doi:10.1016/j.jtcvs.2009.08.058.
[21] Suri RM, Clavel M-A, Schaff HV, Michelena HI, Huebner M, Nishimura RA, et al. Effect of Recurrent Mitral Regurgitation Following Degenerative Mitral Valve Repair: Long-Term Analysis of Competing Outcomes. J Am Coll Cardiol 2016;67:488–98. doi:10.1016/j.jacc.2015.10.098.